Research study Program year 2023 Source: CMS Open Payments

A 64-Week, Phase 3B, Multi-Center Study Assessing the Efficacy and Safety of Brolucizumab 6Mg Compared to Aflibercept 2Mg in A Treat to Control Regimen in Patients With Neovascular Age-Related MacUlar Degeneration

Research payments

$3,437,404

277 payments

Through program year 2023, $3,437,404 in research payments was reported against A 64-Week, Phase 3B, Multi-Center Study Assessing the Efficacy and Safety of Brolucizumab 6Mg Compared to Aflibercept 2Mg in A Treat to Control Regimen in Patients With Neovascular Age-Related MacUlar Degeneration, across 277 payments, paid by Novartis Pharmaceuticals Corporation.

Paid by: Novartis Pharmaceuticals Corporation
ClinicalTrials.gov: No trial number was reported for this study

By program year

5 rows

Year	Kind	Amount	Payments
2023	Research	$98,340	52
2022	Research	$478,475	54
2021	Research	$1,987,652	78
2020	Research	$835,516	78
2019	Research	$37,422	15

Breakdown

Who paid Research payments · program years 2019–2023

Novartis Pharmaceuticals Corporation $3,437,404 277 payments

Who received the money Research payments · program years 2019–2023

Charles Retina Institute Organisation paid for research $269,376 3 payments
Pinnacle Research Institute Organisation paid for research $222,190 2 payments
Austin Retina Associates Organisation paid for research $175,057 4 payments
Retina Consultants Of Texas Organisation paid for research $148,374 6 payments
Salehi Retina Institute INC Organisation paid for research $141,078 1 payment
Medical Center Ophthalmology Associates Organisation paid for research $125,298 4 payments
Midwest Eye Institute Organisation paid for research $109,621 5 payments
Graystone Eye Organisation paid for research $108,320 6 payments
Vitreoretinal Surgery Organisation paid for research $106,266 2 payments
Prairie Retina Center Organisation paid for research $103,379 3 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.